Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Optimizing Tarlatamab Delivery in Small Cell and Neuroendocrine Lung Cancer: Real-World Insights into Step-Up Dosing and Prophylactic Tocilizumab Use.
Journal: Clinical lung cancer
Published: September 21, 2025
CD40L stimulates tumor-infiltrating B-cells and improves ex vivo TIL expansion.
Journal: Journal for immunotherapy of cancer
Published: March 24, 2025
Art of TIL immunotherapy: SITC's perspective on demystifying a complex treatment.
Journal: Journal for immunotherapy of cancer
Published: December 03, 2024
Beyond Chemoimmunotherapy in Advanced Non-Small Cell Lung Cancer: New Frontiers, New Challenges.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: May 23, 2024
Pegargiminase Plus First-Line Chemotherapy in Patients With Nonepithelioid Pleural Mesothelioma: The ATOMIC-Meso Randomized Clinical Trial.
Journal: JAMA oncology
Published: February 15, 2024
Impaired T cell and neoantigen retention in time-serial analysis of metastatic non-small cell lung cancer in patients unresponsive to TIL cell therapy.
Journal: Nature cancer
Published: January 09, 2024
Clinical Outcomes of Patients with Non-Small Cell Lung Cancer Leptomeningeal Disease Following Receipt of EGFR-Targeted Therapy, Immune-Checkpoint Blockade, Intrathecal Chemotherapy, or Radiation Therapy Alone.
Journal: Clinical lung cancer
Published: November 30, 2023
Phase 2 Trial of Nivolumab and Ramucirumab for Relapsed Mesothelioma: HCRN-LUN15-299.
Journal: JTO clinical and research reports
Published: June 30, 2023
Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial.
Journal: Nature medicine
Published: December 20, 2020
Last Updated: 09/26/2026